Patents implicate divergent economic interests. Most new drugs would never be marketed without patent protection. Yet patent assertions by non-practicing entities are blamed with costing the electronics industry and consumers over $29 billion a year.
The America Invents Act (AIA) tries to balance these interests and harmonize with patent systems in other countries. Starting next month, these goals are in part ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In